Metraipolis › archive › dc_64635d7effee

What should infectious diseases clinicians know about pharmacy benefit managers and their impact on our patients? — Europe PMC PMID:41562028

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41562028
DOI
10.1017/ash.2025.10277
License (as archived)
solo-consultazione
Archived
2026-11-06T20:26:15.281Z
SHA-256 of the archived text
d7f301c0a98f00d0b46a47845e5b207ae6888bb9d287246e3a9b6429f0b14d4c
Stable URL of this page
https://metraipolis.com/documento/dc_64635d7effee

How to cite

What should infectious diseases clinicians know about pharmacy benefit managers and their impact on our patients? — Europe PMC PMID:41562028 — Europe PMC (en), https://europepmc.org/article/MED/41562028 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_64635d7effee (Metraipolis archive dc_64635d7effee, sha256 d7f301c0a98f00d0b46a47845e5b207ae6888bb9d287246e3a9b6429f0b14d4c)
BibTeX
@misc{dc64635d7effee,
  title = {What should infectious diseases clinicians know about pharmacy benefit managers and their impact on our patients? — Europe PMC PMID:41562028},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41562028},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_64635d7effee; sha256 d7f301c0a98f00d0b46a47845e5b207ae6888bb9d287246e3a9b6429f0b14d4c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41562028. Agents can read the archived copy with the MCP tool read_document.